$DMK News
Last published 2y ago
- 2y agoDMKDMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHIGlobeNewswireSAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK) ("DMK"), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment
- 2y agoDMKDMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateGlobeNewswireSAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of
- 2y agoDMKDMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewswireRebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid related deaths through enhanced sales of ZIMHI® and thus
- 2y agoDMKDMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023GlobeNewswireSAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of
- 3y agoDMKDMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireSAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial-stage biopharmaceutical company, today announced that the compensation committee of the board of directors
- 3y agoDMKDMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireSAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial-stage biopharmaceutical company, today announced that the compensation committee of the board of directors
- 3y agoDMKFUVDMK Pharmaceuticals Restructures Executive Team to Support Next Phase of GrowthGlobeNewswireSeth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John Dorbin assumes role of General Counsel Corporate Secretary